Loading…
Loading…
The iShares Future AI & Tech ETF aims to deliver investment results that correspond to an index. This index is composed of companies operating both within the U.S. and internationally. These firms are recognized for their contributions to artificial intelligence (AI) technologies, specifically through products and services. Their activities encompass crucial AI segments such as generative AI, AI data and infrastructure, AI software, and AI services.
Is ARTY's expense ratio expensive, average, or a steal for its category?
Pro reveals the verdict on a 5-tier spectrum calibrated against ICI 2025 industry averages, with strategy-aware bands so the comparison is meaningful.
It feels like we're reaching a moment of peak doubt about the AI boom, so investors have big choices to make.
ARTY, WQTM, and ARKX represent a progression from commercial AI to speculative quantum computing and diversified space/defense innovation. ARTY is my highest-conviction Buy, backed by strong earnings, hyperscaler capex, and leading AI hardware/software exposure despite a 37x earnings multiple. WQTM is a speculative buy, offering quantum computing optionality but trading at 119x trailing earnings; position sizing should be small due to high valuation risk.
AI is everywhere in the product. But revenue growth is decelerating, from 16% to 13% to 12% guided. The productivity benefits are arriving for users and end-consumers of AI, though it's not hitting the income statement (at least yet) for most companies.
I downgrade iShares Future AI & Tech ETF from "Buy" to "Hold" after a rapid 40% rally and surging volatility. ARTY's concentrated AI exposure, 31% non-U.S. allocation, and implied volatility above 50% heighten risk amid unstable sector leadership. Valuation remains constructive with a PEG near 1x, but technicals signal potential downside toward $55 if support levels break.
Goldman Sachs models $765 billion in annual AI capital spending for 2026, climbing toward $1.6 trillion by 2031.